Dr Agarwals Health Care Ltd

AI
Dr Agarwal's Hea Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Dr Agarwals Health Care Ltd

₹ 508 0.01%
11 Sep - close price
dragarwals.co.in BSE: 544350 NSE: AGARWALEYE
About

Incorporated in 2010,[1]Dr. Agarwal’s Health Care offers a wide array of eye care services, which include cataract and refractive surgeries, consultations, diagnoses, and non-surgical treatments. Additionally, they provide optical products, contact lenses, accessories, and pharmaceutical items related to eye care. [2]

Key Points

Largest Eyecare Service Provider:[1][2]
Dr. Agarwal is India's largest eye care
service chain with a 26-27% market share.
It is the largest company by revenue in FY25, witnessed faster growth than other organized eye care service market.

Website BSE NSE
  • Market Cap ₹ 16,118 Cr.
  • Current Price ₹ 508
  • High / Low ₹ 568 / 401
  • Stock P/E 109
  • Book Value ₹ 63.9
  • Dividend Yield 0.00 %
  • ROCE 11.1 %
  • ROE 6.81 %
  • Face Value ₹ 1.00
Edit ratios

Pros

Cons

  • Stock is trading at 7.95 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 6.11% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of BSE Healthcare BSE 1000 BSE Hospitals Nifty Microcap 250 Nifty Total Market

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
333 349 403 417 431 460 487 499 530 564 614
244 241 300 310 316 329 360 363 386 403 444
Operating Profit 89 108 104 107 115 131 128 136 144 161 170
OPM % 27% 31% 26% 26% 27% 28% 26% 27% 27% 29% 28%
12 20 6 12 13 13 13 8 11 14 6
Interest 22 27 27 28 28 25 25 23 21 22 23
Depreciation 43 47 56 57 58 60 63 68 69 77 78
Profit before tax 36 54 27 33 41 59 54 54 65 77 75
Tax % 37% 24% 33% 36% 31% 27% 29% 32% 33% 35% 27%
23 41 18 21 28 43 38 36 44 50 55
EPS in Rs 0.72 1.03 0.95 0.94 1.07 1.25 1.43
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
531 471 696 1,018 1,332 1,711 2,080 2,207
407 387 510 743 965 1,248 1,511 1,595
Operating Profit 124 85 186 275 367 463 570 612
OPM % 23% 18% 27% 27% 28% 27% 27% 28%
13 6 17 14 44 43 46 39
Interest 54 44 49 76 101 115 90 89
Depreciation 93 95 98 128 170 231 276 292
Profit before tax -11 -48 57 84 141 160 249 270
Tax % 82% 21% 24% -24% 32% 31% 32%
-21 -59 43 103 95 110 168 185
EPS in Rs 2.64 4.20 4.69
Dividend Payout % 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 35%
3 Years: 27%
TTM: 23%
Compounded Profit Growth
10 Years: %
5 Years: 34%
3 Years: 13%
TTM: 43%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 17%
Return on Equity
10 Years: %
5 Years: 8%
3 Years: 6%
Last Year: 7%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 7 7 7 8 9 32 32
Reserves 242 177 206 622 1,330 1,835 1,994
162 185 633 857 966 961 1,066
339 417 179 336 445 837 850
Total Liabilities 751 787 1,025 1,823 2,751 3,665 3,942
551 575 701 1,293 1,746 2,523 2,879
CWIP 8 11 28 99 118 153 234
Investments 1 0 0 34 471 264 152
192 201 295 397 416 724 676
Total Assets 751 787 1,025 1,823 2,751 3,665 3,942

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
103 99 164 233 346 360 519
-85 -46 -155 -509 -914 -750 -308
-73 -37 35 303 553 382 -220
Net Cash Flow -56 17 44 27 -15 -8 -10
Free Cash Flow -98 66 95 76 118 40 59
CFO/OP 97% 126% 97% 98% 103% 86% 101%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 36 36 30 27 27 26 28
Inventory Days 178 169 144 116 138 181 178
Days Payable 340 452 389 326 355 345 283
Cash Conversion Cycle -126 -247 -215 -183 -190 -138 -76
Working Capital Days -31 -47 -50 -62 -65 -44 -3
ROCE % -1% 17% 13% 11% 10% 11%

Insights

In beta
Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash Payor Mix
%

Log in to view insights

Please log in to see hidden values.

Login
Cataract Surgeries Performed
#
Number of Doctors
#
Number of Emerging Facilities
#
Number of International Facilities
#
Number of Patients Served
#
Total Number of Facilities
#
Total Surgeries Performed
#

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

15 Recently
Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
32.45% 32.43% 32.43% 32.39% 32.35% 32.34%
60.62% 59.26% 58.13% 58.06% 57.94% 57.97%
5.21% 6.44% 7.92% 7.78% 7.83% 7.72%
1.74% 1.87% 1.52% 1.78% 1.87% 1.97%
No. of Shareholders 68,69663,02148,16846,55443,53842,492

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls